Presenilin-1 (PSEN1)

The protein contains 467 amino acids for an estimated molecular weight of 52668 Da.

 

Catalytic subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral membrane proteins such as Notch receptors and APP (amyloid-beta precursor protein) (PubMed:15274632, PubMed:10545183, PubMed:10593990, PubMed:10206644, PubMed:10899933, PubMed:10811883, PubMed:12679784, PubMed:12740439, PubMed:25043039, PubMed:26280335, PubMed:30598546, PubMed:30630874, PubMed:28269784, PubMed:20460383). Requires the presence of the other members of the gamma-secretase complex for protease activity (PubMed:15274632, PubMed:25043039, PubMed:26280335, PubMed:30598546, PubMed:30630874). Plays a role in Notch and Wnt signaling cascades and regulation of downstream processes via its role in processing key regulatory proteins, and by regulating cytosolic CTNNB1 levels (PubMed:9738936, PubMed:10593990, PubMed:10899933, PubMed:10811883). Stimulates cell-cell adhesion via its interaction with CDH1; this stabilizes the complexes between CDH1 (E-cadherin) and its interaction partners CTNNB1 (beta-catenin), CTNND1 and JUP (gamma-catenin) (PubMed:11953314). Under conditions of apoptosis or calcium influx, cleaves CDH1 (PubMed:11953314). This promotes the disassembly of the complexes between CDH1 and CTNND1, JUP and CTNNB1, increases the pool of cytoplasmic CTNNB1, and thereby negatively regulates Wnt signaling (PubMed:9738936, PubMed:11953314). Required for normal embryonic brain and skeleton development, and for normal angiogenesis (By similari (updated: May 8, 2019)

Protein identification was indicated in the following studies:

  1. Goodman and co-workers. (2013) The proteomics and interactomics of human erythrocytes. Exp Biol Med (Maywood) 238(5), 509-518.
  2. Hegedűs and co-workers. (2015) Inconsistencies in the red blood cell membrane proteome analysis: generation of a database for research and diagnostic applications. Database (Oxford) 1-8.
  3. Bryk and co-workers. (2017) Quantitative Analysis of Human Red Blood Cell Proteome. J Proteome Res. 16(8), 2752-2761.

Methods

The following articles were analysed to gather the proteome content of erythrocytes.

The gene or protein list provided in the studies were processed using the ID mapping API of Uniprot in September 2018. The number of proteins identified and mapped without ambiguity in these studies is indicated below.
Only Swiss-Prot entries (reviewed) were considered for protein evidence assignation.

PublicationIdentification 1Uniprot mapping 2Not mapped /
Obsolete
TrEMBLSwiss-Prot
Goodman (2013)2289 (gene list)227853205992269
Lange (2014)123412347281224
Hegedus (2015)2638262202352387
Wilson (2016)165815281702911068
d'Alessandro (2017)18261817201815
Bryk (2017)20902060101081942
Chu (2018)18531804553621387

1 as available in the article and/or in supplementary material
2 uniprot mapping returns all protein isoforms as one entry

The compilation of older studies can be retrieved from the Red Blood Cell Collection database.

The data and differentiation stages presented below come from the proteomic study and analysis performed by our partners of the GReX consortium, more details are available in their published work.

No sequence conservation computed yet.

This protein is annotated as membranous in Gene Ontology, is annotated as membranous in UniProt, is predicted to be membranous by TOPCONS.


Interpro domains
Total structural coverage: 90%
Model score: 132

(right-click above to access to more options from the contextual menu)

VariantDescription
AD3
AD3
AD3
AD3
AD3
frontotemporal dementia
AD3
AD3; impaired protease activity with APP and increased amyloid-beta 42/amyloid-beta 40 ratio
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
dbSNP:rs1042864
AD3
AD3
AD3
AD3
Probable disease-associated variant found in a patient with dementia
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
Found in a renal cell carcinoma sample; somatic mutation
dbSNP:rs17125721
CMD1U
AD3; decreased protease activity with APP; results in altered amyloid-beta production and increased amyloid-beta 42/amyloid-beta 40 ratio
AD3
AD3
AD3
AD3; unknown pathological significance; decreased protease activity with APP; results in altered amyloid-beta production and increased amyloid-beta 42
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3
Abolishes gamma-secretase activity
AD3
Abolishes gamma-secretase activity
AD3
AD3
AD3
AD3
AD3
AD3
AD3
AD3; unknown pathological significance
AD3
AD3
AD3
AD3
AD3
PIDB and AD3
AD3
AD3
AD3
AD3
AD3; abolishes protease activity with APP
AD3
AD3
AD3
AD3
AD3
AD3
AD3
Probable disease-associated variant found in patients with late-onset
AD3; unknown pathological significance
AD3
AD3
AD3
AD3; unknown pathological significance

Biological Process

Activation of MAPKK activity GO Logo
Amyloid precursor protein catabolic process GO Logo
Amyloid precursor protein metabolic process GO Logo
Amyloid-beta formation GO Logo
Amyloid-beta metabolic process GO Logo
Astrocyte activation GO Logo
Astrocyte activation involved in immune response GO Logo
Autophagosome assembly GO Logo
Blood vessel development GO Logo
Brain morphogenesis GO Logo
Cajal-Retzius cell differentiation GO Logo
Calcium ion transmembrane transport GO Logo
Calcium ion transport GO Logo
Canonical Wnt signaling pathway GO Logo
Cell fate specification GO Logo
Cell-cell adhesion GO Logo
Cellular response to amyloid-beta GO Logo
Cellular response to DNA damage stimulus GO Logo
Cerebellum development GO Logo
Cerebral cortex cell migration GO Logo
Choline transport GO Logo
Dorsal/ventral neural tube patterning GO Logo
Embryonic limb morphogenesis GO Logo
Endoplasmic reticulum calcium ion homeostasis GO Logo
Ephrin receptor signaling pathway GO Logo
Epithelial cell proliferation GO Logo
Extracellular matrix disassembly GO Logo
Extracellular matrix organization GO Logo
Heart looping GO Logo
Hematopoietic progenitor cell differentiation GO Logo
Intracellular signal transduction GO Logo
L-glutamate import across plasma membrane GO Logo
L-glutamate transmembrane transport GO Logo
Learning or memory GO Logo
Membrane protein ectodomain proteolysis GO Logo
Membrane protein intracellular domain proteolysis GO Logo
Memory GO Logo
Mitochondrial transport GO Logo
Modulation of age-related behavioral decline GO Logo
Myeloid dendritic cell differentiation GO Logo
Negative regulation of apoptotic process GO Logo
Negative regulation of apoptotic signaling pathway GO Logo
Negative regulation of axonogenesis GO Logo
Negative regulation of core promoter binding GO Logo
Negative regulation of epidermal growth factor-activated receptor activity GO Logo
Negative regulation of gene expression GO Logo
Negative regulation of neuron apoptotic process GO Logo
Negative regulation of transcription by RNA polymerase II GO Logo
Negative regulation of ubiquitin-dependent protein catabolic process GO Logo
Negative regulation of ubiquitin-protein transferase activity GO Logo
Neural retina development GO Logo
Neuron apoptotic process GO Logo
Neuron development GO Logo
Neuron migration GO Logo
Neuron projection maintenance GO Logo
Neutrophil degranulation GO Logo
Notch receptor processing GO Logo
Notch receptor processing, ligand-dependent GO Logo
Notch signaling pathway GO Logo
Positive regulation of amyloid fibril formation GO Logo
Positive regulation of apoptotic process GO Logo
Positive regulation of catalytic activity GO Logo
Positive regulation of coagulation GO Logo
Positive regulation of dendritic spine development GO Logo
Positive regulation of gene expression GO Logo
Positive regulation of glycolytic process GO Logo
Positive regulation of L-glutamate import across plasma membrane GO Logo
Positive regulation of MAP kinase activity GO Logo
Positive regulation of phosphorylation GO Logo
Positive regulation of proteasomal ubiquitin-dependent protein catabolic process GO Logo
Positive regulation of protein binding GO Logo
Positive regulation of protein import into nucleus GO Logo
Positive regulation of protein import into nucleus, translocation GO Logo
Positive regulation of receptor recycling GO Logo
Positive regulation of transcription, DNA-templated GO Logo
Positive regulation of tumor necrosis factor biosynthetic process GO Logo
Positive regulation of tumor necrosis factor production GO Logo
Post-embryonic development GO Logo
Protein glycosylation GO Logo
Protein maturation GO Logo
Protein processing GO Logo
Protein transport GO Logo
Regulation of canonical Wnt signaling pathway GO Logo
Regulation of gene expression GO Logo
Regulation of neuron projection development GO Logo
Regulation of phosphorylation GO Logo
Regulation of protein binding GO Logo
Regulation of resting membrane potential GO Logo
Regulation of synaptic plasticity GO Logo
Regulation of synaptic transmission, glutamatergic GO Logo
Response to oxidative stress GO Logo
Sequestering of calcium ion GO Logo
Single organismal cell-cell adhesion GO Logo
Skeletal system morphogenesis GO Logo
Skin morphogenesis GO Logo
Smooth endoplasmic reticulum calcium ion homeostasis GO Logo
Somitogenesis GO Logo
Synapse organization GO Logo
Synaptic vesicle targeting GO Logo
T cell activation involved in immune response GO Logo
T cell receptor signaling pathway GO Logo
Thymus development GO Logo

The reference OMIM entry for this protein is 104311

Presenilin 1; psen1
Ps1
S182

DESCRIPTION

The PSEN1 gene encodes presenilin-1, which forms the catalytic component of gamma-secretase. Gamma-secretase is responsible for proteolytic cleavage of amyloid precursor protein (APP; 104760) and NOTCH receptor proteins (see 190198). Gamma-secretase is a multiprotein complex consisting of PSEN1 or its homolog PSEN2 (600759), nicastrin (605254), APH1 (see APH1A, 607629), and PEN2 (PSENEN; 607632) (summary by De Strooper, 2003; Chau et al., 2012).

CLONING

By linkage mapping, Sherrington et al. (1995) defined a minimal cosegregating region containing the candidate gene for early-onset Alzheimer disease type 3 (607822), which had been linked to chromosome 14q24.3. Of 19 different transcripts isolated, 1 transcript, designated S182 by them, corresponded to a novel gene that encoded a 467-amino acid protein. Human and murine amino acid sequences shared 92% identity. Northern blot analysis identified a major 3-kb transcript expressed in most regions of the human brain and in several peripheral tissues. Structural analysis predicted an integral membrane protein with at least 7 transmembrane helical domains. The Alzheimer's Disease Collaborative Group (1995) isolated full-length cDNA clones for what they referred to as the PS1 gene. Contrary to previous mapping data, they found that the gene maps just telomeric to D14S77. The location at the 5-prime end of a specific YAC enabled them to determine that the gene is oriented 5-prime/3-prime centromere-telomere. Evidence for alternative splicing of the gene was found. Thinakaran et al. (1996) observed a polypeptide of approximately 43 kD in cells transfected with full-length human PS1 cDNA. Using 2 highly specific antibodies against nonoverlapping epitopes of presenilin-1, they demonstrated that the preponderant PS1-related species that accumulate in cultured mammalian cells and in the brains of rodents, primates, and humans are approximately 27-kD N-terminal and about 17-kD C-terminal derivatives. Epitope mapping analysis showed that PS1 cleavage occurred between amino acids 260 and 320. In brains of transgenic mice expressing human PS1, the 17-kD and the 27-kD PS1 derivatives accumulate to saturable levels, and at about 1:1 stoichiometry, independent of transgene-derived mRNA. The authors concluded that PS1 is subject to endoproteolytic processing in vivo. In a British familial Alzheimer disease (FAD) pedigree, a PS1 variant with a deletion of amino acids 290 to 319 (delE9) (104311.0012) was not cleaved. Rogaev et al. (1997) determined that alternative splicing produces several PSEN1 transcripts which encode distinct protein sequences; exon 9 is specifically removed from PSEN1 transcripts in leukocytes but not in most other tissues. PSEN1 transcripts are polyadenylated at 2 alternative sites. Mercken et al. (1996) produced 7 monoclonal antibodies that react with 3 nonoverlapping epitopes on the N-terminal hydrophilic tail of PS1. The monoclonal antibodies can detect the full-size 47-kD PS1 and the more abundant 28-kD degradation product in membrane extracts from human brain and human cell lines. PC12 cells transiently transfected with PS1 constructs containing 2 different Alzheimer mutations, M146V (104311.0007) and A246E (104311.0003), failed to generate the 28-kD degradation product in contrast to PC12 cells transfected with wildtype PS1. Mercken et al. (1996) suggested that type 3 Alzheimer disease may be the result of impaired proteolytic processing of PS1. La ... More on the omim web site

Subscribe to this protein entry history

May 11, 2019: Protein entry updated
Automatic update: Entry updated from uniprot information.

Feb. 22, 2019: Protein entry updated
Automatic update: Entry updated from uniprot information.

Dec. 9, 2018: Protein entry updated
Automatic update: Entry updated from uniprot information.

Feb. 10, 2018: Protein entry updated
Automatic update: Entry updated from uniprot information.

Feb. 2, 2018: Protein entry updated
Automatic update: Uniprot description updated

Dec. 19, 2017: Protein entry updated
Automatic update: Uniprot description updated

Nov. 23, 2017: Protein entry updated
Automatic update: Uniprot description updated

June 20, 2017: Protein entry updated
Automatic update: comparative model was added.

March 16, 2016: Protein entry updated
Automatic update: OMIM entry 104311 was added.

Jan. 25, 2016: Protein entry updated
Automatic update: model status changed